Dr. Robert Nagourney In The News
Here are informative videos, TV segments, and articles where our founder Dr. Robert Nagourney discusses cancer biology and how we use laboratory testing to help select the most effective and least toxic drug treatment.
The Future of Cancer Research Lies Behind Us
- Robert A. Nagourney, MD
PRESS COVERAGE
Nagourney Cancer Institute Challenges “Death Sentence” Mindset in Stage 4 Pancreatic Cancer
Laboratory Method Has Proven Effective Finding Treatments for Metastatic Pancreatic Cancer, Offering Hope for Patients Facing This Deadly Cancer
​
​
January 29, 2026
Metabolic Patterns in Pancreatic Cancer Could Lead to Earlier Diagnosis
Pancreatic ductal adenocarcinoma remains a challenge to treat due to its complex biology and resistance mechanisms.
​
​“We crafted a small pilot study, taking 10 known pancreatic cancer plasma samples and comparing them with our entire database of almost 800 others,” Robert A. Nagourney, MD, the study’s lead author, explained. The samples included both cancerous and noncancerous specimens.
​
January 25, 2025
Dr. Nagourney on
CBS News
Los Angeles
In this episode of The Moss Report Podcast, Ralph W. Moss speaks with Dr. Robert Nagourney about his well-documented approach to precision oncology. Nagourney’s strategy takes a step away from genetic sequencing. By taking a biopsy of a tumor, he claims to be able to deduce what treatments will be effective for an individual. Also in this episode is a discussion about repurposed drugs for cancer treatment, including the use of Metformin.
Dr. Nagourney has appeared multiple times on "Extra" for his work with celebrity clients.
News Wire
Dr. Nagourney’s Effective Cancer Treatment Shows Promising Results
​
One prominent practicing oncologist, Dr. Robert Nagourney, has pioneered a technique that is currently having double the success rate of standard cancer treatment.
Wall Street Journal
Every Cancer Patient Is One in a Billion
​
The disease’s endless variety is reminiscent of Tolstoy’s observation about unhappy families.
Technology
Networks
Repurposing and Combining Drugs – An Effective Cancer Treatment Strategy
Nagourney is having success investigating whether a unique combination of existing and approved cancer drugs might be more effective compared to “off-the-shelf” treatments.
USA TODAY
Mom of six fought terminal breast cancer to live for her kids.
​
"A complete pathological response. Complete pathological response in this setting is associated with a 90% chance of being disease-free at three years."
Digital Journal
Killing cancer first in a lab may replace generic treatment
In one meta-analysis of over 2500 peer-reviewed, published outcomes, patients who received “active” drugs selected in the laboratory had a 2.04 fold higher response rate ( P < 0.001) and a 1.44 fold higher one-year survival (p = 0.02).
